About the Lipids Online Slide Library

The Lipids Online Slide Library is a collection of educational talks by the Editorial Board on the current approaches to managing atherosclerosis and other lipid-related disorders. Each talk contains slides, talking points, references that are linked to PubMed, and key words that allow you to find additional slides on a similar topic. Each talk can be individually viewed or the slide library can be searched by key word to assemble a custom presentation. Talks and customized presentations can be downloaded into PowerPoint on your computer.

A talk can be accessed by clicking on a title below or through "Slide Library" on the navigation bar at the top of this page. More information about an author of a talk is available by clicking on the author's name.

Some talks are offered for CME credit. CME activities can be accessed by clicking on "View as a CME Activity" below the author's name.

If you have questions about how to use the Slide Library, please visit Slide Library Help.

Clinical Cases

A Case of Adolescent Obesity: The Role of Bariatric Surgery

Madhuri M. Vasudevan, MD, MPH, and Sanjeev A. Vasudevan, MD

Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication

Vijay Nambi, MD and Madhuri M.Vasudevan, MD, MPH

Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication

Peter H. Jones, MD

A Mexican American Woman with Multiple Metabolic Risk Factors

Stephen Haffner, MD

Benefits of Moderate Weight Loss in Reducing Cardiometabolic Risk

Peter H. Jones, MD

The Patient with Severe Hypertriglyceridemia

Christie M. Ballantyne, MD

Management of the Patient with Familial Hypercholesterolemia

Peter H. Jones, MD

The Patient with a Statin Intolerance

Peter H. Jones, MD

Lipid Treatment and Goal Attainment: A Hispanic Male with CHD and Diabetes

Peter H. Jones, MD

Cardiometabolic Risk

Prevention of Diabetes

Steven Haffner, MD

View as a CME activity

Therapeutic Options for Modifying Cardiovascular and Metabolic Risk Factors

Louis J. Aronne, MD

View as a CME activity

Visceral Adipose Tissue and Cardiometabolic Risk: Does It Really Matter? Part 1

Jean-Pierre Després, PhD

View as a CME activity

Visceral Adipose Tissue and Cardiometabolic Risk: Does It Really Matter? Part 2

Jean-Pierre Després, PhD

View as a CME activity

The Biology of the Endocannabinoid System and Its Relation to Obesity

STEPHEN C. WOODS, PHD

View as a CME Activity

Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient

TIM CHURCH, MD, MPH, PHD

View as a CME Activity

The Metabolic Syndrome: Introduction and Definitions

STEVEN M. HAFFNER, MD

View as a CME Activity

Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease

ANTHONY N. FABRICATORE, PHD, AND THOMAS A. WADDEN, PHD

View as a CME Activity

C-Reactive Protein: A Marker of Risk

PETER W. F. WILSON, MD

Epidemiology of Insulin Resistance, Diabetes Mellitus and CHD

STEVEN M. HAFFNER, MD

Evolving Concepts in Lipid Management

Role of Omega-3 Fatty Acids in Cardiovascular Disease Prevention

William S. Harris, PhD

View as a CME Activity

C-Reactive Protein: A Target of Therapy

Christopher P. Cannon, MD

Combination Lipid-Altering Drug Therapy with Statins: An Update

Harold Bays, MD

Cholesterol Metabolism and the Concept of Dual Inhibition

David E. Cohen, MD, PhD

Guidelines for Risk Assessment and Management

AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them

Gregg C. Fonarow, MD

View as a CME Activity

Lifestyle Interventions: Dietary Therapy, Physical Activity, Weight Control

Neil J. Stone, MD

Selecting Successful Lipid-Lowering Treatments

James M. McKenney, PharmD

ATP III: New Approaches in Identifying and Treating High-Risk Patients

Steven M. Haffner, MD

New Evidence and the Guidelines: Is a Revision Needed?

Heart Protection Study

Rory Collins, MB BS

Dyslipidemia, Inflammation and Atherosclerosis

Sitosterolemia: A Rare Genetic Disorder Leads to Insight into an Important Physiological Process

Shailesh B. Patel, BM, ChB, FRCP

Inflammatory Markers, Pharmacotherapy and Clinical Trials

Paul Ridker, MD
Christie M. Ballantyne, MD

Inflammation and Pathogenesis of Atherothrombotic Disease

Peter Libby, MD

Role of Lipoproteins in Inflammation

Philip J. Barter, MD, PhD

Epidemiology of Inflammatory Markers and CHD: Evidence for High-Sensitivity C-Reactive Protein

Paul Ridker, MD

Dyslipidemia, Diabetes and CHD

Diabetic Dyslipidemia and Atherosclerosis

Henry Ginsberg, MD

Clinical Trials and Guidelines for Lipid Management in the Diabetic Patient

Steven M. Haffner, MD

Clinical Evaluation and Nonlipid Treatment of CAD in the Diabetic Patient

Richard Nesto, MD

HDL and Coronary Heart Disease

Coronary Imaging and Coronary Event Trials

B. Greg Brown, MD

View as a CME Activity

Current and Emerging Pharmacologic Approaches to Targeting HDL

Michael H. Davidson, MD

View as a CME Activity

Evidence to Support Aggressive Management of HDL-C: Implications of Recent Trials

Allen J. Taylor, MD

View as a CME Activity

HDL as a Therapeutic Target

Daniel J. Rader, MD

Epidemiology of CHD

Thomas P. Bersot, MD, PhD
Steven M. Haffner, MD

Physiology and Pathophysiology of HDL Metabolism

Daniel J. Rader, MD

Effects of Lifestyle and Dietary Modification on HDL-C Levels

Margo A. Denke, MD